Despite the pessimistic statement, Bancel indicated that “he believes that the Corona vaccine developed by his company will be effective against infection with any of the new virus variants spread in the United Kingdom, South Africa and Brazil.”
The European Medicines Agency announced on January 6 that it had given the green light to use the American “Moderna” vaccine against the emerging corona.The European Medicines Agency said in a statement that “the European Medicines Agency recommended granting a license to conditionally market the moderna vaccine against Covid-19, to prevent people from being infected with the Corona virus from the age of 18 years.”
In addition, the US Food and Drug Administration announced, last December, its approval to grant an emergency license to use the Moderna vaccine.
The Moderna vaccine is similar to the Pfizer-Biontech vaccine, which was licensed and shipped to vaccinate the first batch of Americans earlier in December.
The most important difference between the two vaccines is that what “Moderna” produces can be stored in regular refrigerators and does not require an ultra-cold transport network, which makes it more accessible for small facilities and remote areas.
The moderna vaccine needs to be stored between 2 and 8 degrees Celsius for a period of 30 days, while the Pfizer vaccine needs to be minus 60 degrees Celsius to store it for the same period.
The effectiveness of the “Moderna” vaccine against Covid-19 exceeded 94 percent, and it is obtained at least two weeks after the second dose, according to a document issued by an advisory committee to the US Food and Drug Administration.
Like its counterpart from “Pfizer”, the “Moderna” vaccine uses “mRNA” technology that stimulates the body to produce proteins similar to those on the surface of the virus, so that the body begins to produce the appropriate antibodies, which can confront the real virus if it enters the body.
It is worth noting that Moderna is a biotechnology company, founded in 2010, and headquartered in Massachusetts, and its scientists collaborated with researchers from the National Institutes of Health to produce a vaccine for another Coronavirus, which is the Middle East Respiratory Syndrome (MERS).